NCT06067984View on ClinicalTrials.gov

An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

September 12, 2023

Primary Completion Date

June 13, 2025

Study Completion Date

August 22, 2025

Conditions
SchizophreniaNegative Symptoms in Schizophrenia
Interventions
DEVICE

Study App

An investigational prescription digital therapeutic in the form of a smartphone app.

Trial Locations (1)

10013

Click Therapeutics, New York

Sponsors

Collaborators (1)

Boehringer Ingelheim
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Click Therapeutics, Inc.

INDUSTRY